Sarah Sheehan is a Managing Associate at the Duke-Margolis Center for Health Policy working on biomedical innovation, medical product development, and regulatory science initiatives. Sarah’s work at the Center focuses primarily on issues related to the design and conduct of clinical trials.
Before joining Duke, Sarah was a Health Policy Analyst at the United States Government Accountability Office (GAO) and a Researcher at the Centers for Disease Control and Prevention (CDC). At GAO and CDC, Sarah’s research covered policies related to incentivizing the development of new antimicrobials and approaches to preventing healthcare-associated infections.
Mark McClellan, Gregory Daniel, Sarah Sheehan, Morgan Romine, Elizabeth Richardson, Jessica Burnell, Meredith Freed, Becky Briesacher, Stacie Dusetzina, Chester Good, Kenneth Hornbuckle, Joseph Ross